NCT02183402View on ClinicalTrials.gov

Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2008

Conditions
Healthy
Interventions
DRUG

Digoxin

DRUG

BI 1356

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY